Search results for "HERA"

showing 10 items of 14928 documents

Long‐term treatment with the oncolytic ECHO‐7 virus Rigvir of a melanoma stage IV M1c patient, a small cell lung cancer stage IIIA patient, and a his…

2016

Oncolytic virotherapy is a recent addition to cancer treatment. Here, we describe positive treatment outcomes in three patients using Rigvir virotherapy. One of the patients is diagnosed with melanoma stage IV M1c, one with small cell lung cancer stage IIIA, and one with histiocytic sarcoma stage IV. The diagnoses of all patients are verified by histology or cytology. All patients started Rigvir treatment within a few months after being diagnosed and are currently continuing Rigvir treatment. The degree of regression of the disease has been determined by computed tomography. Safety assessment of adverse events graded according to NCI CTCAE did not show any value above grade 1 during Rigvir(…

0301 basic medicineMicrobiology (medical)Oncologymedicine.medical_specialtyPathologymedicine.medical_treatmentHistiocytic sarcomaPathology and Forensic Medicine03 medical and health sciences0302 clinical medicineInternal medicineImmunology and AllergyMedicineVirotherapyAdverse effectProspective cohort studybusiness.industryMelanomaGeneral MedicineImmunotherapymedicine.diseaseOncolytic virus030104 developmental biology030220 oncology & carcinogenesisSmall Cell Lung CarcinomabusinessAPMIS
researchProduct

Bacteriophages: Protagonists of a Post-Antibiotic Era

2018

This article belongs to the Special Issue Bacteriophages: Alternatives to Antibiotics and Beyond.

0301 basic medicineMicrobiology (medical)Phage therapyPhage therapyAntibiotic resistancemedicine.drug_classmedicine.medical_treatmentAntibioticsReviewBiologyBiochemistryMicrobiologyEnzybiotics03 medical and health sciencesAntibiotic resistancemedicineBacteriophagesPharmacology (medical)General Pharmacology Toxicology and Pharmaceuticsbusiness.industrylcsh:RM1-950Ecological safetyEnzybioticsBiotechnologylcsh:Therapeutics. Pharmacology030104 developmental biologyInfectious DiseasesPhage displaybusinessAntibiotics
researchProduct

Phages for biofilm removal

2020

This article belongs to the Special Issue Phage Therapy, Lysin Therapy, and Antibiotics, a Trio Due to Come.

0301 basic medicineMicrobiology (medical)Phage therapyPhage therapyAntibiotic resistancemedicine.medical_treatmentviruses030106 microbiologyReviewBiochemistryMicrobiologycomplex mixturesbiofilmMicrobiologyBacteriophage03 medical and health sciencesAntibiotic resistancemedicinePharmacology (medical)General Pharmacology Toxicology and PharmaceuticsBacteriophagebiologyChemistrylcsh:RM1-950Polymeric matrixBiofilmbiochemical phenomena metabolism and nutritionbiology.organism_classificationlcsh:Therapeutics. Pharmacology030104 developmental biologyInfectious DiseasesBiofilmsbacteriaBacteria
researchProduct

Scoping the effectiveness and evolutionary obstacles in using plasmid-dependent phages to fight antibiotic resistance

2016

Aim: To investigate the potential evolutionary obstacles in the sustainable therapeutic use of plasmid-dependent phages to control the clinically important conjugative plasmid-mediated dissemination of antibiotic resistance genes to pathogenic bacteria. Materials & methods: The lytic plasmid-dependent phage PRD1 and the multiresistance conferring plasmid RP4 in an Escherichia coli host were utilized to assess the genetic and phenotypic changes induced by combined phage and antibiotic selection. Results & conclusions: Resistance to PRD1 was always coupled with either completely lost or greatly reduced conjugation ability. Reversion to full conjugation efficiency was found to be rare…

0301 basic medicineMicrobiology (medical)Phage therapymedicine.medical_treatment030106 microbiologyBiologymedicine.disease_causeMicrobiologyMicrobiology03 medical and health sciencesPlasmidAntibiotic resistanceDrug Resistance BacterialEscherichia colimedicineHumansBacteriophagesEscherichia coliEscherichia coli InfectionsGeneticsBacterial conjugationPathogenic bacteriaAnti-Bacterial AgentsLytic cycleConjugation GeneticHorizontal gene transferPlasmidsFuture Microbiology
researchProduct

2019

Aquaculture production has increased tremendously during the last decades, and new techniques have been developed, e.g., recirculating aquaculture systems (RAS). In RAS, the majority of water volume is circulated via mechanical and biological filters and reused in the tanks. However, the prevention and treatment of diseases in these systems are challenging, as the pathogens spread throughout the system, and the addition of chemicals and antibiotics disrupts the microbiome of the biofilters. The increasing antibiotic resistance has made phage therapy a relevant alternative for antibiotics in food production. Indeed, as host-specific and self-replicating agent they might be optimal for target…

0301 basic medicineMicrobiology (medical)Phage therapymedicine.medical_treatmentFish farming030106 microbiologyBiochemistryMicrobiologyMicrobiologyBacteriophage03 medical and health sciencesAquaculturemedicinePharmacology (medical)14. Life underwaterGeneral Pharmacology Toxicology and Pharmaceuticsbiologybusiness.industryBiofilmbiology.organism_classification6. Clean water030104 developmental biologyInfectious DiseasesFlavobacterium columnareBiofilterRainbow troutbusinessAntibiotics
researchProduct

A New Water-Soluble Bactericidal Agent for the Treatment of Infections Caused by Gram-Positive and Gram-Negative Bacterial Strains

2020

Grapefruit and lemon pectin obtained from the respective waste citrus peels via hydrodynamic cavitation in water only are powerful, broad-scope antimicrobials against Gram-negative and -positive bacteria. Dubbed IntegroPectin, these pectic polymers functionalized with citrus flavonoids and terpenes show superior antimicrobial activity when compared to commercial citrus pectin. Similar to commercial pectin, lemon IntegroPectin determined ca. 3-log reduction in Staphylococcus aureus cells, while an enhanced activity of commercial citrus pectin was detected in the case of Pseudomonas aeruginosa cells with a minimal bactericidal concentration (MBC) of 15 mg mL&minus

0301 basic medicineMicrobiology (medical)Staphylococcus aureusfood.ingredientPectinlemon030106 microbiology<i>Staphylococcus aureus</i>grapefruitmedicine.disease_causeBiochemistryMicrobiologyArticle03 medical and health sciencesAntibiotic resistancefoodmedicineflavonoidPharmacology (medical)Citrus PectinFood scienceantimicrobial resistanceGeneral Pharmacology Toxicology and PharmaceuticspolyphenolsIntegroPectinMinimum bactericidal concentrationbiologyChemistryPseudomonas aeruginosalcsh:RM1-950food and beveragesAntimicrobialbiology.organism_classificationcitrus pectincarbohydrates (lipids)<i>Pseudomonas aeruginosa</i>polyphenollcsh:Therapeutics. Pharmacology030104 developmental biologyInfectious DiseasesStaphylococcus aureusflavonoidscitrus terpenesPseudomonas aeruginosaStaphylococcus aureucitrus terpeneBacteriaAntibiotics
researchProduct

Enhanced emergence of antibiotic-resistant pathogenic bacteria after in vitro induction with cancer chemotherapy drugs.

2019

International audience; BACKGROUND:Infections with antibiotic-resistant pathogens in cancer patients are a leading cause of mortality. Cancer patients are treated with compounds that can damage bacterial DNA, potentially triggering the SOS response, which in turn enhances the bacterial mutation rate. Antibiotic resistance readily occurs after mutation of bacterial core genes. Thus, we tested whether cancer chemotherapy drugs enhance the emergence of resistant mutants in commensal bacteria.METHODS:Induction of the SOS response was tested after the incubation of Escherichia coli biosensors with 39 chemotherapeutic drugs at therapeutic concentrations. The mutation frequency was assessed after …

0301 basic medicineMicrobiology (medical)Staphylococcus aureusmedicine.drug_class030106 microbiologyAntibioticsAntineoplastic AgentsDrug resistanceMicrobial Sensitivity TestsBiologymedicine.disease_causeMicrobiology03 medical and health sciencesSOS Response (Genetics)0302 clinical medicineAntibiotic resistanceDrug Resistance BacterialEnterobacter cloacaemedicineHumansPharmacology (medical)030212 general & internal medicineMutation frequencySOS responseSOS Response GeneticsPharmacologyPathogenic bacteriaChemotherapy regimen3. Good healthAnti-Bacterial Agents[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyInfectious DiseasesPseudomonas aeruginosaThe Journal of antimicrobial chemotherapy
researchProduct

New Synthetic Nitro-Pyrrolomycins as Promising Antibacterial and Anticancer Agents

2020

: Pyrrolomycins (PMs) are polyhalogenated antibiotics known as powerful biologically active compounds, yet featuring high cytotoxicity. The present study reports the antibacterial and antitumoral properties of new chemically synthesized PMs, where the three positions of the pyrrolic nucleus were replaced by nitro groups, aiming to reduce their cytotoxicity while maintaining or even enhancing the biological activity. Indeed, the presence of the nitro substituent in diverse positions of the pyrrole determined an improvement of the minimal bactericidal concentration (MBC) against Gram-positive (i.e., Staphylococcus aureus) or -negative (i.e., Pseudomonas aeruginosa) pathogen strains as compare…

0301 basic medicineMicrobiology (medical)Staphylococcus aureusmedicine.drug_classAntibioticspyrrolomycinmedicine.disease_causeSettore BIO/19 - Microbiologia Generale01 natural sciencesBiochemistryMicrobiologypyrrolic nucleusHCT116Article03 medical and health sciencesantibacterial activityMCF 7medicinePharmacology (medical)General Pharmacology Toxicology and PharmaceuticsSettore BIO/06 - Anatomia Comparata E CitologiaCytotoxicityheterocyclesMinimum bactericidal concentrationantitumoral activity010405 organic chemistryChemistryPseudomonas aeruginosalcsh:RM1-950MCF7Biological activitySettore CHIM/08 - Chimica Farmaceutica0104 chemical scienceslcsh:Therapeutics. Pharmacology030104 developmental biologyInfectious DiseasesMCF-7BiochemistryStaphylococcus aureusPseudomonas aeruginosaNitroAntibiotics
researchProduct

Immunodominant Cytomegalovirus Epitopes Suppress Subdominant Epitopes in the Generation of High-Avidity CD8 T Cells

2021

CD8+ T-cell responses to pathogens are directed against infected cells that present pathogen-encoded peptides on MHC class-I molecules. Although natural responses are polyclonal, the spectrum of peptides that qualify for epitopes is remarkably small even for pathogens with high coding capacity. Among those few that are successful at all, a hierarchy exists in the magnitude of the response that they elicit in terms of numbers of CD8+ T cells generated. This led to a classification into immunodominant and non-immunodominant or subordinate epitopes, IDEs and non-IDEs, respectively. IDEs are favored in the design of vaccines and are chosen for CD8+ T-cell immunotherapy. Using murine cytomegalov…

0301 basic medicineMicrobiology (medical)Subdominantantigenic peptidesAntigen presentationCD8 T cellsImmunodominanceBiologyArticleEpitopeAntigenic driftprotective immunity03 medical and health sciences0302 clinical medicineMHC class IImmunology and AllergyCytotoxic T cellcytomegalovirusMolecular BiologyimmunodominanceGeneral Immunology and MicrobiologyRVirologyepitope(s)antigen presentation030104 developmental biologyInfectious Diseasesvaccine designbiology.proteinMedicineimmunotherapyCD8030215 immunologyPathogens
researchProduct

Occurrence and Antimicrobial Resistance of Arcobacter spp. Recovered from Aquatic Environments

2021

Arcobacter spp. are emerging waterborne and foodborne zoonotic pathogens responsible for gastroenteritis in humans. In this work, we evaluated the occurrence and the antimicrobial resistance profile of Arcobacter isolates recovered from different aquatic sources. Besides, we searched for Arcobacter spp. in seaweeds and the corresponding seawater samples. Bacteriological and molecular methods applied to 100 samples led to the isolation of 28 Arcobacter isolates from 27 samples. The highest prevalence was detected in rivers followed by artificial ponds, streams, well waters, and spring waters. Seaweeds contained a higher percentage of Arcobacter than the corresponding seawater samples. The is…

0301 basic medicineMicrobiology (medical)Water samplesVeterinary medicineAntibiotic susceptibilityArcobacter cryaerophilusTetWTetracyclinemedicine.drug_class030106 microbiologyAntibioticsTetOBiochemistryMicrobiologyArticle03 medical and health sciencesAntibiotic resistancemedicinePharmacology (medical)General Pharmacology Toxicology and PharmaceuticsbiologyAquatic ecosystemlcsh:RM1-950Arcobacter butzleri<i>Arcobacter butzleri</i>Multiplex PCRbiology.organism_classificationIsolation (microbiology)Arcobacter butzlerilcsh:Therapeutics. Pharmacology030104 developmental biologyInfectious DiseasesArcobacter<i>tetO</i><i>tetW</i>medicine.drugAntibiotics
researchProduct